CNS Pharmaceuticals Inc <CNSP.OQ> expected to post a loss of $9.60 a share - Earnings Preview
CNS Pharmaceuticals Inc CNSP.OQ CNSP.O is expected to report resultson August 12 (estimated) for the period ending June 30 2025
LSEG's mean analyst estimate for CNS Pharmaceuticals Inc is for a loss of $9.60 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The average consensus recommendation for the biotechnology & medical research peer group is "Hold".
Wall Street's median 12-month price target for CNS Pharmaceuticals Inc is $84.00, about 92% above its last closing price of $6.70
This summary was machine generated August 11 at 12:46 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
Related Articles
[Reuters Analysis] Can Nvidia results dispel creeping AI doubts?: McGeever
By Jamie McGeeverORLANDO, Florida, Aug 26 (Reuters) - Questions are arising about when artificial intelligence will deliver its promised returns, meaning tech-concentrated U.S. equity indices sitting near record highs are vulnerable to a correction. Nvidia's quarterly results this week could the...
Nvidia Q2 Earnings Expectations: With Little Room for Error, Will China-Related Risks Be Magnified?
TradingKey - Ahead of Nvidia Q2 FY2026 earnings report, multiple Wall Street firms have raised their price targets on Nvidia, reflecting strong confidence in AI demand. While analysts continue to forecast robust ~50% year-over-year growth in revenue and EPS, the China variable remains a major risk
Trump to Sack Cook: Why the Fed Must Maintain Its Independence?
TradingKey - On 25 August 2025, Trump announced the immediate dismissal of Cook from her position as a Federal Reserve Governor, citing "false statements in mortgage loan documents." On the surface, this appears to be an action targeting an individual official's conduct.
What to Watch in Nvidia’s Q2 FY2026 Earnings: AI Growth, Margins, and Market Impact
TradingKey - NVIDIA Corporation (NASDAQ: NVDA) will report its Q2 FY2026 earnings on Wednesday, August 27, 2025, after the U.S. market closes. The earnings call is scheduled for 5:00 p.m. Eastern Time. With Nvidia being a bellwether in AI, gaming, and data center markets, and carrying significant...
Eurozone Q2 GDP Commentary: Will the Euro's Upward Momentum Persist?
TradingKey - On 14 August 2025, Eurostat published Q2 GDP figures, revealing a drop in the Eurozone's quarter-on-quarter growth from 0.6% in the first quarter to 0.1%. Consequently, annual growth eased from 1.5% to 1.4%. The slowdown primarily stems from the diminishing boost from European...
